Corcept Therapeutics Inc. buy Quitte
Start price
03.11.15
/
50%
€3.66
Target price
03.05.16
€4.80
Performance (%)
12.61%
End price
03.05.16
€4.12
Summary
This prediction ended on 03.05.16 with a price of €4.12. The prediction had a final performance of 12.61%. Quitte has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Corcept Therapeutics Inc. | 8.159% | 8.159% | 43.283% | 51.711% |
| iShares Core DAX® | 0.611% | -2.723% | 14.325% | 14.359% |
| iShares Nasdaq 100 | -0.208% | 6.703% | 37.781% | 55.710% |
| iShares Nikkei 225® | 1.298% | 1.009% | 9.641% | 4.825% |
| iShares S&P 500 | 0.636% | 5.035% | 30.827% | 48.685% |
Comments by Quitte for this prediction
In the thread Corcept Therapeutics Inc. diskutieren
sieht nach Raketenstart aus
macht sich in meinem Depot "Gesundmacher" sehr gut, jetzt soll sie auch hier beweisen, was sie kann
Seattle Genetics carries a Zacks Rank #4 (Sell). Some better-ranked stocks in the health care sector are Anacor Pharmaceuticals, Corcept Therapeutics Incorporated CORT
3.69 +0.32 (8.67%)
. Both carry a Zack Rank #2 (Buy).
(Laufzeit überschritten)